Has Tecentriq earned a role in treatment of triple-negative breast cancer? Here is what experts say

FDA’s review of “dangling indications” continues beyond PD-1 and PD-L1 drugs

FDA officials said the questions about accelerated approval of PD-1 and PD-L1 drugs have been largely resolved, thanks in part to guidance from the Oncologic Drugs Advisory Committee.

October 15, 2021

Vol.47 No.38

By Paul Goldberg

Cancer History Project Guest Editorial

Tackling health equity and Latinx representation in medicine as U.S. Hispanic population grows

Spanning part of September and October, it is a time to celebrate and recognize Hispanics or Latinos or Latinx persons* for their contributions. This nationwide observation begins on Sept. 15 when several countries in Latin America celebrate independence—Costa Rica, El Salvador, Guatemala, Honduras, and Nicaragua. Mexico celebrates independence on Sept. 16 and Chile on Sept. 18. Towards the end of Hispanic Heritage Month, Oct. 12 is also recognized as Día de la Raza.1 Persons of Hispanic ancestry have walked the Americas since 1492.

Joseph R. Bertino made fundamental discoveries in oncology, was president of ASCO, AACR

Joseph R. Bertino, a physician who made fundamental discoveries in cancer biology, defined curative cancer treatment regimens, trained generations of influential cancer researchers, ran productive laboratories, and served as the inaugural director of Yale Cancer Center, died on Oct. 10. He was 91.

Remembering Joe Bertino

My dear friend and mentor, Joseph R. Bertino, MD, died Sunday, Oct. 10, 2021, in New Brunswick, NJ, after an extended illness.

AACR Cancer Progress Report underscores need for continued investment in cancer research

Congress needs to increase the FY22 base budgets of NIH and NCI by $3.2 billion and $1.1 billion, respectively, over FY21 levels, the American Association for Cancer Research said in its 2021 Cancer Progress Report.

Janet Rowley: “Take risks”

Before Janet Rowley, few scientists suspected that chromosomal aberrations caused cancer. Beginning in the 1970s, however, she made a series of fundamental discoveries demonstrating that specific chromosomal changes caused certain types of leukemia.

October 15, 2021

Vol.47 No.38

Has Tecentriq earned a role in treatment of triple-negative breast cancer? Here is what experts say

YOU MAY BE INTERESTED IN

FDA’s review of “dangling indications” continues beyond PD-1 and PD-L1 drugs

Tackling health equity and Latinx representation in medicine as U.S. Hispanic population grows

Joseph R. Bertino made fundamental discoveries in oncology, was president of ASCO, AACR

Remembering Joe Bertino

AACR Cancer Progress Report underscores need for continued investment in cancer research

Janet Rowley: “Take risks”

Renew today!

Subscriber content

Login